Apnimed, Inc.
$17.56
Mkt Cap 731.0M
Developer of oral drug therapies for obstructive sleep apnea, a condition in which breathing repeatedly stops during sleep.
apnimed.com ↗Summary by The Compound Family, based on the company’s own website
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
Run a full DCF model with Monte Carlo simulation.
Key Metrics
Loading full analysis…
Running full 6-factor analysis…